You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

phase II/III

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)

Not yet recruiting
  • Hepatic Ascites
  • Recombinant Human Serum Albumin
  • Human serum albumin
  • Guangdong, Shenzhen, China
    Shenzhen Protgen Ltd
May 5, 2023

Retinitis Pigmentosa Trial (1.5 x 10^6 UC-MSC + CM, 5 x 10^6 UC-MSC + CM)

Not yet recruiting
  • Retinitis Pigmentosa
  • 1.5 x 10^6 UC-MSC + CM
  • 5 x 10^6 UC-MSC + CM
  • (no location specified)
Jun 11, 2023

Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,

Not yet recruiting
  • Colorectal Cancer
  • HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
  • HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
  • (no location specified)
Jul 13, 2023

Metastatic Cancer Trial in London (Arm 2: SABR, Arm 1: Standard of Care)

Not yet recruiting
  • Metastatic Cancer
  • Arm 2: SABR
  • Arm 1: Standard of Care
  • London, Ontario, Canada
    London Health Sciences Centre- London Regional Cancer Program
Aug 17, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (QL1706, Carrelizumab, Gemcitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangzhou, China
    Sun Yat-sen University Cancer Center
Oct 21, 2022

Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets 400mg, SPH4336 Tablets Placebo)

Not yet recruiting
  • Locally Advanced or Metastatic Breast Cancer
  • SPH4336 Tablets 400mg
  • SPH4336 Tablets Placebo
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital, Sun Yat-sen University
Feb 24, 2023

Covid-19 Vaccine Trial (PIKA COVID-19 vaccine)

Not yet recruiting
  • Covid-19 Vaccine
  • PIKA COVID-19 vaccine
  • (no location specified)
Jul 17, 2022

BK Viremia Trial (Anti-BK polyomavirus (AntiBKV))

Not yet recruiting
  • BK Viremia
  • Anti-BK polyomavirus (AntiBKV)
  • (no location specified)
Mar 3, 2023

Uterine Fibroids With Menorrhagia Trial (SHR7280 tablets, PlaceboSHR7280 tablets blank preparation)

Not yet recruiting
  • Uterine Fibroids With Menorrhagia
  • SHR7280 tablets
  • PlaceboSHR7280 tablets blank preparation
  • (no location specified)
Jun 28, 2022

Inclusion Body Myositis Trial (ABC008)

Not yet recruiting
  • Inclusion Body Myositis
  • (no location specified)
Feb 9, 2023

Nasopharyngeal Carcinoma, TNF, Chemo-radiotherapy Trial (5-fu, Cisplatin, Radiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +2 more
  • (no location specified)
Jun 22, 2022

Amyotrophic Lateral Sclerosis Trial (Acetyl-l-carnitine, Placebo)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Nov 9, 2023

COVID-19, Symptoms and Signs, COVID-19 Pandemic Trial in Cortés (Chlorpheniramine Maleate 0.4% Nasal Spray, Placebo)

Completed
  • COVID-19
  • +4 more
  • Chlorpheniramine Maleate 0.4% Nasal Spray
  • Placebo
  • Cortés, San Pedro Sula, Honduras
    Hospital CEMESA
Jun 1, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

Type 1 Diabetes Trial in Toronto, Vancouver (Ustekinumab, Placebo)

Recruiting
  • Type 1 Diabetes Mellitus
  • Toronto, British Columbia, Canada
  • +1 more
Jun 3, 2022

Obstructive Sleep Apnea Trial (IHL-42X Low Dose, IHL-42X High Dose, Placebo)

Not yet recruiting
  • Obstructive Sleep Apnea
  • IHL-42X Low Dose
  • +5 more
  • (no location specified)
Nov 22, 2023

HER2 Gene Mutation Trial (Injection of IAH0968 + CAPEOX, PLACEBO+CAPEOX)

Not yet recruiting
  • HER2 Gene Mutation
  • Injection of IAH0968 + CAPEOX
  • PLACEBO+CAPEOX
  • (no location specified)
Jan 4, 2023

COVID-19 Trial (LYB001, Placebo)

Not yet recruiting
  • COVID-19
  • LYB001
  • Placebo
  • (no location specified)
Oct 26, 2022

NSCLC Trial (PM8002, Placebo, Carboplatin)

Not yet recruiting
  • NSCLC
  • (no location specified)
Feb 23, 2023

Coronavirus Infections, Healthy Trial in Valinhos (NDV-HXP-S 10µg, BNT162b2 30µg)

Not yet recruiting
  • Coronavirus Infections
  • Healthy
  • NDV-HXP-S 10μg
  • BNT162b2 30μg
  • Valinhos, São Paulo, Brazil
    Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda.
May 16, 2022

Rectal Cancer Trial in Mecca (Chemotherapy)

Recruiting
  • Rectal Cancer
  • Mecca, Makkah Western, Saudi Arabia
    King Abdullah Medical City, Holy Capital
Apr 5, 2022

MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • +3 more
  • (no location specified)
Apr 23, 2023

Antithrombin III Deficiency Trial (Plasma-derived AT-III concentrate)

Active, not recruiting
  • Antithrombin III Deficiency
  • Plasma-derived AT-III concentrate
  • (no location specified)
May 5, 2022

Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)

Not yet recruiting
  • Cervical Cancer
  • Recombinant humanized anti-PD-1 monoclonal antibody injection
  • +4 more
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Nov 3, 2023

Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)

Recruiting
  • Mucopolysaccharidosis III-A
  • Hamburg, Germany
    Universitätsklinikum Hamburg-Eppendorf
Oct 18, 2023